breast cancer remains a leading cause of cancer death among women in the United States. More than 180,000 new cases of invasive breast cancer are diagnosed each year, and more than 40,000 women die of the disease. Recent years, however, have seen improvements in survival attributed to better treatment and earlier diagnosis. Research efforts have been directed toward better treatment, preventive strategies, and early detection. Although mammography has been the mainstay of early detection, its limitations are well recognized and the search for more effective technologies for early detection has been receiving increased attention. As part of this increased attention, the Institute of Medicine (IOM) convened a committee to examine the current state of the art in early breast cancer detection, to identify promising new technologies, and to examine the many steps in medical technology development and the policies that influence their adoption and use. The IOM committee consisted of a 16-member interdisciplinary group with a wide range of views and expertise in breast cancer, medical imaging, cancer biology, epidemiology, economics, and technology assessment. The committee examined the peer-reviewed literature, met four times, held two workshops that dealt with new technologies as well as policies related to their adoption and dissemination, and consulted with experts in the field.
 |
| Mammography and Beyond: Developing Technologies for the Early Detection of Breast Cancer |
1 Introduction
2 Breast Imaging and Related Technologies
3 Technologies in Development: Genetics and Tumor Markers
4 Development and Regulation of New Technologie
5 Evaluation and Cost Coverage of New Technologies
6 Dissemination: Increasing the Use and Availability of New Technologies
7 Findings and Recommendations
Express Your Opinions in comments
EmoticonEmoticon